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Abstract.  Transforming growth factor beta (TGF-13) is 
angiogenic in vivo. In vitro, endothelial cell prolifera- 
tion is inhibited by TGF-13. We have correlated this in- 
hibitory effect with an increase in cellular fibronectin 
synthesis and deposition in a  two-dimensional culture 
system using specific matrix coatings. The inhibitory 
effect was mimicked by addition of soluble fibronectin 
to cultures. In contrast, TGF-13 was found to elicit the 
formation of tube-like structures (mimicking angiogen- 
esis) when microvascular endothelial cells were grown 
in three-dimensional collagen gels.  In this culture sys- 
tem TGF-[3 elicited rapid extensive formation of com- 
plex, branching, tube-like structures, while cell 
proliferation was not inhibited. These data confirm and 
support the hypothesis that TGF-13 is angiogenic and 
may exert some of its effects through modulation of 
matrix synthesis and are consistent with the hypothesis 
that the organization of the extracellular environment 
influences cellular responses to this "panregulin" 
GIOGENESIS (the formation of new blood vessels from 
endothelial cells) is a complex process involving en- 
dothelial  cell  activation  (including  synthesis  and 
secretion of proteases), migration, and proliferation, as well 
as matrix synthesis, differentiation, multicellular organiza- 
tion, stabilization, and capillary endothelial cell regression 
of local endothelial cell populations during healing and re- 
pair (Furcht,  1986; Madri and Pratt,  1987). Previously, we 
have demonstrated the importance of extracellular matrix 
(ECM) t composition and organization (laminin and type IV 
collagen)  in  the  regulation of endothelial cell  migration, 
proliferation, and multicellular organization during angio- 
genesis (Madri and Williams, 1983; Pratt et al., 1984, 1985; 
Form et al., 1986). Although ECM appears to be an impor- 
tant modulator of angiogenesis, it is but one element in a 
complex control mechanism which also makes use of various 
soluble factors including platelet-derived growth factor and 
transforming growth factor beta (TGF-[3). Recently, TGF-[3 
(a 25-kD  homodimer that has been shown to control cell 
growth and differentiation) has been noted to elicit a striking 
angiogenic response in mice as well as to dramatically affect 
synthesis in vivo and in vitro (Roberts et al.,  1986). Ignotz 
and Massague (1986) have demonstrated a functional involve- 
ment of fibronectin in mediating some cellular responses to 
TGF-13 in fibroblasts and have suggested a model for TGF-13 
action based on the modulation of ECM in the target cell. 
Since TGF-13 is present in platelets and inflammatory cells 
it is reasonable to postulate that this protein may function as 
1. Abbreviations used in this paper:  ECM, extracellular matrix; Fn, fibro- 
nectin; Ln, laminin; TGF-[3, transforming growth factor beta; IV, type IV 
collagen; V, type V collagen. 
a paracrine mediator of the repair process, affecting local en- 
dothelial cell behavior by modulating matrix synthesis and 
degradation in the local cell populations in the injured area 
(Sporn et al.,  1986; Saksela et al.,  1987). In this report we 
show that in two-dimensional cultures, matrix-mediated en- 
dothelial cell proliferation is modulated by TGF-D. We also 
demonstrate that this effect is, in part, related to an increase 
in fibronectin synthesis and can be mimicked by addition of 
soluble fibronectin to the cultures. Furthermore, we demon- 
strate that the physical environment of the endothelial cells 
(two- vs. three-dimensional culture), in part, modulates the 
endothelial cell response to this factor. Specifically,  in three- 
dimensional cultures TGF-13 does not inhibit proliferation 
and elicits  rapid  and  extensive tube  formation associated 
with the presence of type V collagen. 
Materials and Methods 
Growth Factors 
TGF-[3 (prepared as described by Assoian et al., 1983) was the generous girl 
of Drs. Michael Sporn and Anita Roberts, Laboratory of Chemoprevention, 
National Cancer Institute,  National Institutes of Health,  Bethesda, MD. 
Epidermal growth factor receptor grade was purchased from Collaborative 
Research, Lexington, MA, and used without further purification. 
Antibodies 
Affinity-purified antibodies to human plasma fibronectin, human placental 
membrane type V collagen (V), murine Engelbreth-Holm-Swarm laminin, 
and type IV collagen, and rat skin acid soluble type I and III collagen were 
produced as described. Cross-reactivity profiles have been previously deter- 
mined (Roll  et al.,  1980; Madri et al.,  1980). 
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Immunofluorescence was performed on fixed, permeabilized cultures as 
previously described using a  rhodamine-conjugated goat anti-rabbit sec- 
ondary  antibody  (Cappel  Laboratories,  Cochranville,  PA)  (Leto et  al., 
1986).  Immunofluorescence of frozen sections of three-dimensional cul- 
tures (see below) was performed as described (Nicosia and Madri,  1987). 
Matrix Components and Coating Protocol 
Human plasma fibronectin (In), calf dermal type I collagen, murine Engel- 
breth-Holm-Swarm tumor-derived laminin (Ln), and murine Engelbreth- 
Holm-Swarm tumor-derived type  IV  collagen (IV)  were prepared and 
purified as described (Madri and Furthmayr, 1980; Madri et at., 1980; Roll 
et al., 1980). Fibronectin was further purified by gel filtration chromatogra- 
phy on a 2.5￿  100-cm Sephacryl S-200 column in the same dissociative, 
acidic buffer (1.0 M KBr, 50 mM Tris-HCl, pH 5.0) that was used for elution 
from the denatured type I collagen affinity column (Yannariello-Brown et 
al.,  1988; Murray et al.,  1978). 35-ram diameter bacteriologic plastic petri 
dishes (model No.  1008; Falcon Lahware, Oxnard, CA) were coated with 
either Fn,  Ln, or IV as described and quantitation of amounts of matrix 
component bound was accomplished by quantitative ELISA inhibition assay 
(Fn  =  0.8 p.g; Ln  =  1.2 ~tg; IV  =  0.63  lag) (Form et al.,  1986). 
Cell Culture 
Capillary endothelial cells were isolated and cultured from rat epididymal 
fat pads as described (Madri and Williams, 1983). All bovine fetal (Gibco, 
Grand Island,  NY)  sera used was first passed over a  gelatin-Sepharose 
column  followed by  passage  over  an  antifibronectin Sepharose CL-4B 
column to remove any endogenous fibronectin. Column-passed sera had a 
fibronectin level of <0.2 ng/ml as determined by quantitative ELISA inhibi- 
tion assay (Madri and Barwick,  1983). 
Proliferation Assays 
Matrix-coated dishes were washed in PBS before the addition of  cell suspen- 
sions (1.4 ￿  104 cells/dish). After 6 h, samples were counted to determine 
starting cell numbers on each substrate. At this time fresh media or media 
containing factors (TGF-13, epidermal growth factor, soluble Fn, or soluble 
Ln) were added to the cultures. In the cases of the TGF-I~ and epidermal 
growth factor studies, the media was replaced once again on day 3. In the 
soluble Fn and Ln addition studies, the matrix component was added every 
12 h for the duration of the experiment. Cell numbers were determined by 
lifting the cells off the culture dishes with trypsin/EDTA and counting qua- 
druplicate samples using a Coulter counter (Coulter Electronics, Inc., Hia- 
leah, FL). The mean number of cells per dish for each matrix coating and 
factor addition was then calculated.  Alternatively, DNA was quantitated 
using DAPI (4',6"-diamidoino-2-phenylindole: Hoechst No.  33258)  in a 
fluorescence assay as described (LaBarca and Paigen,  1980). Amounts of 
DNA were related to cell number by correlating ~g of DNA with cell num- 
bers using serial dilutions of cells. 
Quantitation of  Medium and Cell Layer 
ECM Components 
Concentrations of ECM components (Fn, Ln, IV, and V) in medium and 
cell layer fractions of cultures incubated in the presence and absence of 
TGF-I3 were determined by quantitative ELISA inhibition assay sensitive to 
0.1 ng (Madri and Williams,  1983; Davis et al,,  1987). Medium and cell 
layer fractions of 5-d cultures (+0.5 ng/ml TGF-I3) were collected. Medium 
samples were made 0.1% with Triton X-100 and stirred overnight at 4~ 
Cell layer samples were scraped and extracted into 2.0 M urea, 50 mM Tris- 
HCt, pH 7.2, and stirred overnight at 4~  Serial dilutions of standard Fn, 
Ln, IV, and V samples and the medium and cell layer samples were analyzed 
by ELISA as described (Madri and Williams,  1983;  Davis et al.,  1987). 
Amounts of ECM component/cell (or I~g DNA) were determined from three 
assays of duplicate samples. 
Determination of  Protein Synthesis Levels 
The effect of TGF-13 on overall protein synthesis was evaluated in cultures 
grown on Ln, IV, and Fn. Briefly, cultures were incubated in the absence 
and presence of 0.5 ng/ml TGF-13 for 5 d. On the 4th d media containing 
50 ~tCi of [3H]proline  and leucine were added to the cultures. After 24 h 
the medium fractions were collected, the culture dishes washed three times 
with cold PBS, and the cell layer fractions harvested by scraping into 10% 
cold TCA.  The medium fractions were made 10% with TCA.  After a 24-h 
incubation at 4~  the precipitates were collected and washed by filtration 
over GFA filters (Whatman Inc., Clifton, N J). The filters were then placed 
in scintillation vials,  10 ml of hydrafluor was added, and the vials were 
counted in a liquid scintillation counter (model No. LS 2300; Beckman In- 
struments, Palo Alto, CA) after thorough mixing. Relative protein synthetic 
rates were determined by dividing the sum of the medium and cell layer 
counts by the cell numbers obtained for cultures grown on each of the matrix 
components in the absence and presence of TGF-13. 
Three-dimensional Culture of  CapiUary Endothelial 
Cells: The Effects of TGF-~ 
For studies in a  three-dimensional environment, gels composed of acid- 
soluble calf dermis collagen were used. Briefly, the purified collagen was 
solubilized in 10 mM acetic acid at a concentration of 5.0 mg/ml and stored 
at 4~  (Madri and Furthmayr,  1980), A measured amount of the collagen 
was neutralized with sterile 1 M NaOH and an appropriate amount of 10￿ 
DME was added and the solution held at 4~  After this, cultured capillary 
endothelial cells at a concentration of 2.5  ￿  105/ml were added to the col- 
lagen solution. 300 vtl of this solution were then added to 12-mm Millicell- 
HA filter wells (Millipore Corp., Bedford, MA) placed in a 24-well cluster 
tissue culture dish (Costar, Cambridge, MA) and the dish placed in a 37~ 
humidified 5 % CO2 incubator to permit gel formation. After gel formation 
(10 min), 200 Ixl of medium (+0.5 ng/ml TGF-13) was pipetted over the gel 
(in the inner well) and 700 p.l of medium (:t:0.5 ng/ml TGF-13) was pipetted 
in the outer well, equalizing the fluid  levels of the inner and outer wells. 
Equilibration of the TGF-13 in the medium compartment after instillation in 
the inner well was determined to be 4 h using horseradish peroxidase-type 
VI as an enzymatic marker (data not shown). The qX3F-13 concentration of 
0.5 ng/ml was used because it was determined to be a concentration that 
elicited maximal "tube formation" (data not shown). Medium was replaced 
twice weekly.  Samples were fixed in 10% buffered fbrmalin and examined 
by routine histological sectioning and staining. 
Alternatively, endothelial cells were plated directly onto gelatin-coated 
Millicells filter wells, allowed to attach, and then overlaid with 300 ~tl of 
collagen solution. After gel formation, the cultures were overlaid with me- 
dium as discussed above. 
These cultures were analyzed morphologically using routine fixation, 
paraffin embedding, 6-ltm sections, and Hemotoxylin and Eosin staining. 
Cell density was determined by counting cells per unit area. Organization 
of cells into tubes and ringlike structures was also evaluated. Photomicro- 
graphs were taken on an Olympus Vanox microscope with ltford XP-I film. 
Medium and cell layer (gel)  fractions of 7-d three-dimensional cultures 
(+0.5 ng/ml TGFq3) were collected. Medium samples were made 0.1% with 
Triton X-IO0 and stirred overnight at 4~  Cell layer (gel)  samples were 
placed into 2.0 M urea, 50 mM Tris-HCl, pH 7.2, and stirred overnight at 
4~  Serial dilutions of standard Fn, Ln, IV, and V samples and the medium 
and cell layer san~ples were analyzed by ELISA as described (Madri and 
Williams, 1983; Davis et al., 1987). Amounts of ECM component per cell 
(or per vtg DNA for three-dimensional cultures) were determined from three 
assays of duplicate samples. 
Three-dimensional cultures were assayed for DNA content using the 
DAPI fluorescence assay after dissolution of the collagen gel and isolation 
of the cells (Yang et al.,  1982). 
Results 
TGF-~ Down Regulates Capillary Endothelial Cell 
Proliferation in a Dose-related Fashion 
We have previously shown that selected ECM components 
have different effects on endothelial cell and vascular smooth 
muscle cell proliferation in vitro (Form et al.,  1986). As il- 
lustrated  in  Fig.  l,  laminin-coated dishes  elicited a  high 
proliferative response, type IV collagen an intermediate re- 
sponse, and fibronectin a low proliferative rate. Using lam- 
inin-coated dishes we assayed the ability of TGF-I~ to affect 
proliferative rate. As illustrated in Fig. 2, low concentrations 
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crovascular  endothelial  cells 
on  35-mm-diam  bacteriologic 
plastic  petri dishes  coated with 
either  laminin  (Ln),  type  IV 
collagen  (/V),  and  fibronectin 
(Fn). Cells were seeded at 1.0 ￿ 
104 per dish.  Duplicate  dishes 
were counted at 6 h and on day 3 
and  5  after  plating.  Standard 
errors  are  represented  by  the 
short horizontal  bars over each 
column. 
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of TGF-I~  dramatically affect the proliferative  rate of these 
cells plated on a  laminin substrate.  Significant inhibition  is 
noted at 0.05 ng, and appears maximal at the 0.5-5.0 ng range 
(Fig. 2 a). Similar results were observed with cells plated on 
type IV collagen-coated dishes, although the maximal prolif- 
erative rate on this matrix  is somewhat lower than that ob- 
served on laminin (Fig. 2 b). When TGF-I~ was added to cul- 
tures incubated on Fn-coated dishes, inhibition of  the already 
low proliferative rate was also noted (Fig.  2  c).  Epidermal 
growth factor alone (at concentrations of 1, 5, and 10 ng) had 
no effect on the endothelial cell proliferative rates on any of 
the substrates tested.  Furthermore,  when epidermal growth 
factor  (at  1,  5,  and  10  ng)  was  used  in  combination  with 
0.5 ng of TGF-13, no change in the TGF-13 effect was noted 
(Fig.  3). 
Fibronectin Levels in Medium and Cell Layer 
Fractions Increase in Response to TGF-[3 
Previous  studies  have demonstrated  that solid-phase  fibro- 
nectin elicits a low proliferative rate in cultures of microvas- 
cular endothelial  cells  (Form et al.,  1986).  Since  we  (and 
others [Frater-Schroder et al.,  1986; Heimark et al.,  1986; 
Muller et al.,  1987]) have demonstrated that TGF-I~ has the 
ability to down regulate endothelial cell proliferation and it 
has been reported that TGF-13 increases  fibronectin synthe- 
sis,  it  is  reasonable  to  investigate  the  effect  of TGF-13 on 
fibronectin synthesis in microvascular endothelial cells cul- 
tured  on  Ln and  IV  substrates.  Fig.  4  illustrates  a  typical 
ELISA inhibition assay in which medium and cell layer frac- 
tions of cultures of microvascular endothelial cells, grown on 
type IV collagen in the absence or presence of 0.5 ng TGF-13, 
were assayed for fibronectin. As illustrated,  changes in both 
medium and cell layer fractions were noted upon addition of 
TGF-[3. These curves were compared to a standard inhibition 
curve and the amounts of fibronectin present in the samples 
were determined and calculated on a per cell basis.  Table I 
summarizes our quantitative data using an ELISA inhibition 
assay. As noted, on the substrates tested, along with the dra- 
matic decrease in proliferation there was an approximately 
threefold increase in the amount of Fn present in medium and 
cell layer fractions on a per cell basis.  In contrast,  levels of 
laminin  and  types IV and  V  collagen  in medium  and  cell 
layer fractions were not observed to differ appreciably in the 
absence or presence of TGF-13, except when fibronectin was 
used as the substrate  where types IV and V  collagen were 
noted to be increased in the presence of TGF-13. Distribution 
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Figure 2.  Proliferation  of microvascular  endothelial  cells on lami- 
nin (Ln), type IV collagen (IV), and fibronectin-coated  (Fn) dishes 
in the absence (crosses) and presence of 0.05 (squares), 0.5 (trian- 
gles), and 5.0 ng (diamonds) of TGF-13. Cells were seeded at 1.0 ￿ 
104 per dish.  Quadruplicate  samples  were counted at 6 h and on 
day 3 and 5 after plating. Standard errors were calculated and found 
to be within the dimensions  of the symbols used in representing  the 
data points. 
of synthesized matrix components into medium and cell layer 
compartments  varied  with  the  individual  component  ana- 
lyzed. Specifically, on both substrates tested, in the presence 
and  absence  of TGF-13,  fibronectin  was  present  predomi- 
nantly in the medium fraction. The other matrix components 
assayed for (Ln, IV, and V) were found in both medium and 
cell layer fractions in approximately equimolar ratios  (data 
not shown). Overall protein synthesis in cultures treated with 
TGF-13 was noted to increase twofold, regardless of substrate, 
Madri et al.  Transforming Growth Factor-~ in Angiogenesis  1377 Figure 3.  Effect  of EGF on  the  inhibition of microvascular en- 
dothelial cell proliferation by TGF-13. Cells (1.0  ￿  104 per dish) 
plated on either laminin (Ln) or type IV collagen (IV) in normal 
medium  and  medium  containing 0.5  ng  TGF-13 were  incubated 
alone or with 1, 5, or 10 ng of EGE  Quadruplicate samples were 
counted at 6 h and on day 3 and 5 after plating. Standard errors are 
represented as the short horizontal bars over each column. 
as compared to identical cultures in the absence of TGF-13 
(l.9-fold increase on Ln and IV and a 2.0-fold increase on Fn). 
Relative amounts of fibronectin and laminin present in cell 
layer fractions in the absence and presence of TGF-13 were 
also assessed by immunofluorescence microscopy using anti- 
bodies against laminin and fibronectin. Fig. 5  illustrates the 
increased staining for fibronectin in the cells and matrix of 
cultures plated on coatings of type IV collagen and laminin 
in the presence of TGF-13. In addition to the changes in inten- 
sity of staining, the pattern of matrix staining changed in the 
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Figure 4.  Representative ELISA inhibition assay for the quantita- 
tion of fibronectin of supernatant (squares) and cell layer (triangles) 
fractions of cultures of microvascular endothelial cells grown on 
laminin-coated dishes in the absence (open symbols) or presence 
(solid symbols) of 0.5 ng TGF-13 for 5 d. Samples were compared 
with a standard fibronectin inhibition curve (+), concentrations de- 
termined and compared on a per cell basis. Duplicate samples were 
assayed and average values obtained. 
Figure 5.  Immunofluorescence micrographs of microvascular en- 
dothelial cells in the absence and presence of TGF-[3. (a) Cells cul- 
tured on type IV collagen in the absence of TGF-[3 and stained with 
anti-fibronectin  revealed  an  intracellular,  granular,  perinuclear 
labeling pattern and a random, delicate extracellular fibrillar label- 
ing pattern. (b) Cells cultured on type IV collagen in the presence 
of TGF-[3 and stained with anti-fibronectin revealed an intense intra- 
cellular, granular labeling pattern and an oriented, coarsely fibrillar 
extracellular labeling pattern. (c) Cells cultured on laminin in the 
absence of TGF-[3 and stained with anti-fibronectin also revealed an 
intracellular, granular, perinuclear labeling pattern and a random, 
delicate extracellular  fibrillar  labeling pattern. (d) Cells cultured on 
laminin in the presence of TGF-[3 and stained with anti-fibronectin 
also revealed an intense intraceilular, granular labeling pattern and 
an  oriented,  coarsely fibrillar extracellular labeling pattern.  (e) 
Cells cultured on type IV collagen in the absence of TGF-I3 and 
stained with anti-laminin exhibited an intracellular, granular, peri- 
nuclear labeling pattern. (f) Cells cultured on type IV collagen in 
the presence of TGF-[3 and stained with anti-laminin exhibited an 
identical labeling pattern and fluorescence intensity.  (g) Cells cul- 
tured on fibronectin in the absence of TGF-[3 and stained with anti- 
laminin also revealed an intracellular, granular, perinuclear label- 
ing pattern.  (h) Cells cultured on  fibronectin in the presence of 
TGF-I] and stained with anti-laminin exhibited an identical intracel- 
lular, granular, perinuclear labeling pattern. 
presence of TGF-I~ from a  random,  short,  delicate fibrillar 
pattern to a  coarse,  oriented,  linear pattern  (Fig.  5,  a-d), 
which  roughly  codistributed  with  linear  actin  filaments 
visualized with fluorescein phalloidin (data not shown).  In 
contrast, laminin staining on cultures plated on type IV col- 
lagen and fibronectin was similar in  intensity and  localiza- 
tion (intracellular, predominately perinuclear in Golgi-like 
patterns) in the absence and presence of TGF-13 (Fig. 5, e-h). 
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Absence and Presence of TGF-13 
ECM component (ng/10  ~ cells) 
Substrate  -TGF-13  +TGF-13  +  Ratio 
Fn  316  1020  [3.~ 
Ln  IV  <10  <10  - 
V  36  40  1.1 
Fn  67  165  [~~4~ 
IV  Ln  50  50  1.0 
V  <I0  <10  - 
Ln  200  220  t. t 
Fn  IV  50  80  1.6 
V  24  70  2.9 
Amounts of fibronectin, Iaminin, type IV and V collagen present in the medium 
and cell layer  fractions of 5-d two-dimensional cultures  were determined  by 
quantitative  ELISA inhibition assay,  added together,  and compared on a per 
cell basis.  Changes  in matrix component synthesis by the addition of TGF-13 
is expressed as a ratio of the amount synthesized in the presence of TGF-13 over 
the amount synthesized in the absence of TGF-IL Values represent the means 
of two assays done in duplicate.  Standard errors were no more than  10%  of 
the values. 
Type V collagen staining of cultures plated on laminin and 
fibronectin also appeared similar in intensity and localization 
in the absence and presence of TGF-13 even though increased 
amounts of type V collagen were noted by ELISA in the pres- 
ence of TGF-13 (data not shown), thus illustrating the relative 
insensitivity and qualitative nature of immunofluorescence 
compared to the ELISA methodology. 
Added Fibronectin Mimics the Effect of TGF-[3 
in Cultures Grown on Laminin and 1~pe IV Collagen 
The above studies (as well as several previously published 
reports [Ignotz and Massague,  1986;  Roberts et al.,  1986]) 
suggest the  possibility that qI3F-13 may exert its  effect on 
proliferative  rate,  in  part,  through  modulation  of matrix 
composition, specifically fibronectin.  We tested this possi- 
bility by adding soluble purified fibronectin to microvascular 
endothelial cell cultures grown on Ln, IV, and Fn substrates. 
As noted in Fig.  6,  cells grown on the three substrates ex- 
hibited different proliferative rates,  Ln having the highest, 
followed by IV and Fn, the lowest. Soluble Fn was added to 
the cultures at 24 and 72 h after plating or at 6,  18,  36, 48, 
60, 72,  84, and 96 h after plating and cell counts were per- 
Figure 7. Light level micrographs of microvascular endothelial cells 
(2.5  ￿  lO  s cells/0.4 cc of collagen gel) cultured in the absence (a 
and d) and presence (b and e) of TGFq3 (0.5 ng/ml). After 2 d of 
culture (a and b) cells are observed interspersed in the gets. How- 
ever, in the presence of TGF-t~, the gels appear to be condensed 
around the ceils (b).  After  1 wk in culture the gels treated with 
TGF-13 have contracted,  compared to controls  (c).  Light micros- 
copy of such  cultures  reveals  predominately  single  cells  inter- 
spersed in the delicate gels in the absence of TGF-13 (d); while in 
the presence  of TGFq~ the cells have formed mutticellular,  com- 
plex, tube-like structures and the gel appears dense and compacted 
(e). 
Figure 6.  Proliferation  of mi- 
crovascular endothelial cells (t.0 
￿  t04 per dish) on laminin (Ln), 
type IV collagen  (IV), and  fi- 
bronectin-coated  (Fn) dishes in 
the  absence  and  presence  of 
soluble fibronectin (sFn)  or solu- 
ble laminin (s/n) (50 Ixg/dish/ 
12  h)  was  determined  after a 
48-h  time  period.  Duplicate 
samples  were  analyzed.  The 
short  horizontal  bars  represent 
the  standard  errors  in  the  ex- 
periment. 
formed at 48 and 96 h. As illustrated, addition of soluble Fn 
(in both instances) caused decreased proliferative rates in the 
Ln and IV cultures to the level of the Fn cultures. Addition 
of soluble Fn to the Fn cultures did not further depress the 
proliferative rate and the addition of soluble Ln to the Fn cul- 
tures did not increase the low proliferative rate. These data 
suggest that soluble Fn can decrease the proliferative rate of 
these cells under these specific culture conditions.  Further- 
more, the addition of soluble Fn at multiple intervals to cul- 
tures plated on Fn did not lower the proliferative rates to the 
levels noted in the presence of TGF-[~ (Fig.  2),  suggesting 
that the purified Fn  is free of TGF-13 (Fava and McClure, 
1987). 
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endothelial cells cultured in collagen gels in the absence (a) and 
presence (b-e) of TGF-13. Cells cultured in the absence of TGF-13 
are noted interspersed in the uniform delicate collagen gel (a); cells 
cultured in the presence of TGF-13 have formed simple and complex 
tube-like structures and have compacted the gel, especially in peri- 
cellular  areas  (b).  Higher magnifications (c and d)  illustrate the 
complex, branching, tube-like structures and the apparent compac- 
tion and organization of the collagen gel in the immediate vicinity 
of the cells. 
Culture of  Capillary Endothelial Cells in a 
Three-dimensional Environment Modulates the 
Effects of TGF-[3 
Since  it is  known that  TGFq3  elicits different cellular be- 
havior patterns depending on whether the cells are cultured 
in two or three dimensions (Ignotz and Massague,  1986; As- 
soian and  Sporn,  1986),  we exposed capillary endothelial 
cells cultured under and in three-dimensional collagen gels 
with TGF-I~. When endothelial cells cultured under a colla- 
gen gel were examined no appreciable migration into the gel 
was noted at early time periods (2-14 d) in the presence or 
absence of TGF-13. At later times (3-4 wk) cultures exposed 
to TGF-I~ exhibited modest migration into the gels (data not 
shown). No appreciable tube formation was observed at any 
time points in the absence or presence of TGF-13. In contrast, 
when  cells  were cultured  in  collagen gels,  marked differ- 
ences in cellular behavior were noted in the presence of TGF- 
13. Cells grown in collagen gels were interspersed throughout 
the gels (Figs.  7, a  and b  and 8, a  and b).  In the presence 
of TGF-I3, the cells appeared to contract the gel earlier and 
to a much greater extent than was noted in cultures without 
TGF-13, as evidenced microscopically by an increased den- 
sity of the gel immediately surrounding the cells (Figs. 7, d 
and e, and 8, c-e) and grossly by a marked reduction in gel 
volume (Fig. 7 c). Additionally, extensive, complex tube-like 
structures  were observed throughout  the  gels  treated with 
TGF-[3, in contrast to the modest number of short and simple 
tube-like structures observed in control cultures (Fig. 9, ar- 
rowheads). When cultures  were kept for longer periods of 
time (3 and 4 wk) more gel contraction and tube-like struc- 
tures appeared in control cultures  (data not shown).  Simi- 
lar to what was observed in the  two-dimensional cultures, 
the  three-dimensional  cultures  also  demonstrated  a  dose- 
response to the added  TGF-13. Specifically, tube formation 
was  observed at  TGF-13 concentrations  of 0.05  ng/ml  and 
above.  Maximal  effect (maximal tube-like  formation)  was 
noted  at  concentrations  of 0.5  ng/ml  with  no  further  in- 
creases  noted  up  to  concentrations  of  5.0  ng  TGF-I3/ml 
medium (data not shown). 
Determination of DNA content of the three-dimensional 
cultures  grown  in  the  absence  and  presence  of 0.5  ng/ml 
TGF-[I for 5 d revealed slightly decreased amounts of DNA 
(17.5 ~tg/culture)  in the presence of TGF-13 as compared to 
control  cultures  (20.0  I.tg/culture),  consistent  with  only  a 
modest inhibition of cell proliferation by q'GF-13 at this time 
point.  Assays at later times (7 and  14 d) revealed no differ- 
ences in DNA content in TGF-I~-containing and control cul- 
tures. The proliferative rate of the three-dimensional cultures 
was determined to be approximately that of two-dimensional 
cultures plated on an Fn substrate in the absence of TGF-13 
(as illustrated  in Fig.  1). 
Immunofluorescence Microscopy and Quantitation 
of  ECM Components in Three-dimensional Cultures 
Reveals Modulation in Matrix Synthesis in Response 
to TGF-~ Distinct  from That Observed 
in Two-dimensional Cultures 
6-I.tm frozen sections of cultures of endothelial cells, grown 
in three-dimensional collagen gels for 1 wk in the presence 
and absence of TGF-13 (0.5  ng/ml), were stained with anti- 
bodies to collagen types I, III, IV, V, laminin, and fibronec- 
tin.  In  the  cultures  treated  with  TGF-13, the  extensive, 
branching, tubelike structures did not label with antibodies 
to types I and III collagen  (data not  shown).  The tubelike 
structures (Fig. 9, a and c) labeled intensely with antibodies 
to type V  collagen  in  a  pericellular,  mixed,  punctate,  and 
fibrillar  pattern  (Fig.  10,  a  and  c).  Laminin  staining  was 
noted to be modestly positive,  labeling the tube-like struc- 
tures in a continuous diffuse pattern (Fig.  11 a). These struc- 
tures also labeled very weakly with antibodies to type IV col- 
lagen in a diffuse, amorphous pattern (data not shown).  In 
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gels in the presence and absence of TGF-13. Note the predominance of tube-like structures in the cultures treated with TGF-I] (a and c) 
as compared to the paucity of such structures in the matched controls (b and d). Arrows indicate tube-like structures. Arrowheads indicate 
individual cells. 
Table II. Extracellular  Matrix Component Synthesis in 
the Absence and Presence of TGF-[3 
ECM component synthesized (ng/~g DNA) 
+_TGF-13 
+5.5 
IV 
-5.0 
+46.2 
V 
-42.0 
+7.7 
Ln 
-7.0 
+22.0 
Fn 
-20.0 
Amounts of fibronectin, laminin, type IV and V collagen present in the medium 
and cell layer fractions of 7-d three-dimensional cultures were determined by 
quantitative EL1SA inhibition assay, added together, and compared on a  per 
p,g DNA basis.  Values represent the means of two assays done  in triplicate. 
Standard errors were no more than  10%  of the values. 
contrast to the intense labeling noted in the two-dimensional 
cultures (Fig. 5), staining for fibronectin was very weak (Fig. 
11  c). Cultures not treated with TGF-13 exhibited much less 
tube formation, and many more single cells and isolated cell 
aggregates were noted (Fig. 9, b and d).  Cells in these cul- 
tures also exhibited intense labeling with antibodies to type 
V collagen (Fig. 10, b and d). Cells also labeled very weakly 
with antibodies to type IV collagen (data not shown). Lami- 
nin and fibronectin staining of these cultures were very weak 
(Fig.  11,  b  and  d).  The  weak  staining  patterns  observed 
compared to the presence of these components (laminin, fi- 
bronectin, and type IV collagen) as demonstrated by ELISA 
(Table II) illustrate the relative lack of sensitivity and qualita- 
tive nature of the immunofluorescence methodology as com- 
pared to the ELISA method used. 
ECM component synthesis in three-dimensional cultures 
in the presence and absence of TGF-13 was also determined 
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with  the  individual  component  analyzed.  Specifically, 
fibronectin and type IV collagen were present in both com- 
partments (Fn  =  1:1  and IV  =  0.7:0.3;  cell layer/medium) 
while laminin and type V  collagen were present predomi- 
nantly  in  the cell layer compartment (Ln  =  1:0 and V  = 
0.9:0.1;  cell layer/medium). In contrast to the findings noted 
in the two-dimensional cultures, no appreciable differences 
in amounts of matrix components synthesized in the pres- 
ence and absence of TGF-[3 were observed and, in particular, 
the  fibronectin levels in  treated  and  control  cultures  were 
identical. 
Figure 10.  Immunofluorescence micrographs of 6-~m frozen sec- 
tions of 1-wk cultures of microvascular endothelial cells cultured in 
collagen gels in the presence  (a and c) and absence (b and d) of 
TGF-13 stained with antibodies to type V collagen. Arrows indicate 
tube-like structures beneath the plane of focus. Arrowheads indi- 
cate tube-like  structures  in the plane of focus, exhibiting linear, 
pericellular  staining. L, lumen of tube-like structure cut in cross 
section.  CB, cell body. 
using  ELISA inhibition  assays.  Cells  cultured  in  collagen 
gels expressed type V collagen as a major matrix component 
while type IV collagen was expressed at a much lower level 
(eightfold  less).  Modest  levels of laminin  and  fibronectin 
were also noted (Table II). Distribution of synthesized matrix 
Figure 11.  Immunofluorescence micrographs of 6-~m frozen sec- 
tions of 1-wk cultures of microvascular endothelial cells cultured in 
collagen gels in the presence  (a and c) and absence (b and d) of 
TGF-I3 stained with antibodies to laminin (a ana b) and fibronectin 
(c and d). Solid arrows indicate tube-like structures noted in a and 
c; open arrows indicate the positions of cell bodies observed in b 
and d. 
Discussion 
Endothelial cell-extracellular matrix interactions have been 
well-studied  during  the  past  several  years  (Madri,  1982; 
Montesano et al.,  1983; Pratt et al.,  1985;  Madri and Pratt, 
1986;  Madri et al.,  1987). It has been shown that the com- 
position,  organization,  and  dimensionality  (two  vs.  three 
dimensions)  of the extracellular matrix can have dramatic 
effects upon large and microvascular endothelial cell attach- 
ment, spreading, migration, proliferation, biosynthetic pro- 
file,  and  multicellular  organization  (Delvos  et  al.,  1982; 
Maciag et al.,  1982;  Madri and Pratt,  1986;  Montesano et 
al.,  1983;  Palotie et al.,  1983;  Pratt et al.,  1985;  Keller et 
al.,  1987). In addition, modulation of the synthesis of matrix 
by endothelial cells appears to have profound effects upon en- 
dothelial cell behavior in several in vitro and in vivo systems 
(Madri  and  Stenn,  1982;  Form et al.,  1986;  Nicosia and 
Madri,  1987). One particular matrix component,  fibronec- 
tin,  has been shown to  be an  important modulator of en- 
dothelial cell behavior. When used as a substratum in the cul- 
ture  of  bovine  calf  aortic  endothelial  cells,  fibronectin 
promotes rapid attachment and spreading but a low prolifera- 
tive rate (Palotie et al.,  1983). In addition, these cells exhibit 
a  very  low  migratory  rate  when  cultured  on  fibronectin 
which correlates with specific organizations of selected cor- 
tical cytoskeletal proteins (fodrin and protein 4.1; Pratt et al., 
1984,  1985; Leto et al.,  1986; Madri, J. A., B. M. Pratt, and 
J.  Yannariello-Brown,  manuscript  submitted  for  publica- 
tion).  Cultured microvascular endothelial cells also exhibit 
a low proliferative rate when grown on a fibronectin substra- 
tum as compared to laminin and collagenous substrata (Form 
et al.,  1986).  However, in a three-dimensional organ culture 
(aortic ring-plasma clot model), newly forming, mitotically 
active capillary tufts exhibit a  complex, delicate,  fibrillar, 
pericetlular  network  composed  of  type  V  collagen  and 
fibronectin, followed by the appearance of laminin.  At later 
times type IV collagen,  as well as type I and III collagen, 
and fibronectin staining become more prominent and type V 
collagen exhibits an amorphous and discontinuous staining 
pattern (Nicosia and Madri,  1987). These data suggest that 
the presence or absence of any one matrix component may 
not be the sole signal determining proliferative rate and an- 
giogenesis,  but  cellular  interactions  with  several  matrix 
components (including but not limited to types V and IV col- 
lagen, fibronectin, and laminin) in a three-dimensional lat- 
tice as well as selected interactions of cell adhesion mole- 
cules  constitute  mechanisms  (possibly  via  cell  surface 
matrix-binding proteins) by which certain aspects of cell be- 
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et al.,  1987). 
Another mechanism by which cell behavior may be modu- 
lated is via soluble factors, whose activity may be modu- 
lated,  in part,  by the composition and organization of the 
surrounding  matrix  (Ingber et al.,  1987). A  considerable 
number of soluble factors that stimulate microvascular en- 
dothelial cell proliferation, some of which also elicit angio- 
genesis (the formation of new blood vessels by endothelial 
cells) have been identified (Lobb et al.,  1986). However, an- 
giogenesis is a complex phenomenon comprised of several 
different functional  states  of the  affected endothelial  cell 
population  including  stimulation  (including  activation  of 
proteases,  changes in cell surface proteins, and cytoskele- 
ton), migration, proliferation, tube formation, and stabiliza- 
tion; the latter two being associated with a down regulation 
of proliferation  and  the  development  of a  differentiated 
phenotype (Furcht, 1986; Madri and Pratt, 1987). Therefore, 
it is feasible that factors that can down and upregulate en- 
dothelial cell functions (such as TGF-13) be considered "an- 
giogenic factors." 
TGF-13 has been described as a "panregulin" by Sporn et 
al. (1986), eliciting a high proliferation rate under some con- 
ditions (three-dimensional culture systems) and causing inhi- 
bition of proliferation under other conditions (two-dimen- 
sional culture systems) in selected cell populations (Sporn et 
al.,  1986).  In vivo, investigators have found TGF-13 to be a 
potent stimulator of angiogenesis, whose endpoint is the in- 
growth of capillary tufts (Roberts et al.,  1986). However, in 
vitro, TGF-13 has been found to be an inhibitor of endothelial 
cell proliferation (Frater-Schroder et al., 1986; Muller et al., 
1987). This apparent discrepancy may be resolved if the end- 
point of the in vivo experiments is considered; i.e., capillary 
tuft formation, which is the final result of a complex, orderly 
sequence of processes, occurring in a three-dimensional ma- 
trix,  modulated by an  incompletely understood battery of 
solid-phase and soluble factors. The notion that TGF-13 might 
exert its effects, in part, via modulation of matrix metabolism 
has been postulated (Ignotz and Massague,  1986; Muller et 
al.,  1987; Saksela et al.,  1987). In these studies TGF-13 was 
noted to stimulate matrix (fibronectin and collagen) synthesis 
and decrease urokinase and tissue-type plasminogen activa- 
tor enzyme production. In addition, investigators were able 
to mimic selected TGF-13 effects by the addition of exogenous 
fibronectin and inhibit TGF-13 effects with RGDS-containing 
peptides (Ignotz and Massague,  1986). In the current study, 
using a two-dimensional culture system, we have observed 
similar findings; i.e., that TGF-13 down regulates the prolifer- 
ative rate of cultured microvascular endothelial cells; cells 
incubated with TGF-13 have increased levels of protein syn- 
thesis and markedly increased levels of fibronectin synthesis, 
but not laminin and type IV and V collagen synthesis; also, 
soluble fibronectin added to cultures,  in part,  mimics the 
TGF-13 effect on  cell  proliferative  rate.  Furthermore,  Fn 
mRNA, but not Ln B1 and B2 chain mRNA, was found to 
be  increased  twofold  in  the  presence of TGF-13 (Joseph, 
L. B.,  and  J.  A.  Madri,  unpublished  observations).  Al- 
though these data are consistent with and support the concept 
that TGF-13 increases matrix component synthesis, the possi- 
bility  that  TGF-I3 may  be  having  its  effect by decreasing 
degradation  of matrix  components remains  plausible  and 
both mechanisms may be functioning simultaneously (Sak- 
sela et al.,  1987). 
In addition, similar to others studying different cell popu- 
lations  (Ignotz and  Massague,  1986;  Assoian  and  Sporn, 
1986), we noted dramatic TGF-13-mediated differences when 
microvascular endothelial  cells  were  cultured  in  a  three- 
dimensional environment;  i.e.,  a  loss of the  inhibition of 
proliferation noted in two-dimensional cultures and the rapid 
formation of complex, tubelike structures similar to the an- 
giogenic response noted in vivo (Madri and Williams,  1983; 
Madri and Pratt,  1986).  However, dramatic changes in ma- 
trix expression-specifically, the appearance of type V colla- 
gen as a major extracellular component and the markedly de- 
creased intensity of fibronectin staining and amount noted in 
three-dimensional cultures-were observed both in the ab- 
sence and presence of TGF-13. 
These findings support the hypothesis that TGF-13 has a di- 
rect  effect on  microvascular  endothelial  cell  behavior  in 
vitro, eliciting a differentiated phenotype manifested by tube 
formation (possibly mimicking angiogenesis in vivo) but not 
changes  in  matrix  expression  when  assayed  in  a  three- 
dimensional  culture  system.  Thus,  the  TGF-13 inhibitory 
effect on  microvascular  endothelial  cell  proliferation,  its 
stimulation of Fn and collagen synthesis and  its  observed 
down regulation of urokinase and tissue-type plasminogen 
activators and in vitro angiogenesis in two-dimensional cul- 
ture systems may reflect the influences of both the culture 
systems  used  (two-dimensional  culture  on  tissue  culture 
plastic or on collagen gels) and matrix component metabo- 
lism modulated by TGF-13 (Muller et al., 1987; Saksela et al., 
1987). Similarly, the relative lack of inhibition of prolifera- 
tion and the rapid tube formation noted in the three-dimen- 
sional cultures (culture in collagen gels), stimulated by the 
presence of TGF-13, might reflect more "natural" interactions 
of the cells with their environment and with newly synthe- 
sized matrix components and their receptors, which, in turn, 
may modulate the activities and effects of TGF-13 in ways dis- 
tinct from those observed in two-dimensional culture (Madri 
and Pratt,  1986; Cheifetz et al.,  1987; Ingber et ai.,  1987). 
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